Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2010
12/23/2010CA2764124A1 Substituted isoquinoline derivative
12/23/2010CA2764013A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010CA2763938A1 Herbicidal benzoxazinones
12/23/2010CA2763730A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010CA2755467A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/22/2010EP2264031A2 A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2262801A1 Heterocyclic urea derivatives and methods of use thereof-211
12/22/2010EP2262800A1 Novel pyrimidine-pyridine derivatives
12/22/2010EP2262799A1 Pyridine compounds
12/22/2010EP2262783A2 Covalently binding imaging probes
12/22/2010EP2262772A1 Quinoline derivatives as axl kinase inhibitors
12/22/2010EP1915345B1 Fluoro substituted 2-oxo azepan derivatives
12/22/2010EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925590A Aldh-2 inhibitors in treatment of addiction
12/22/2010CN101925586A Novel heterocyclic compounds
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
12/22/2010CN101921239A Hydrogen di-methyl fluoride substituted isoxazole derivative
12/22/2010CN101220000B Acyl chloride and sulfonyl chloride derivant, and uses thereof
12/21/2010US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
12/21/2010US7855215 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855204 cell surface tyrosine receptor kinases; non-small cell lung cancer; (3-chloro-4-fluoro-phenyl)-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine
12/21/2010US7855201 Morpholine carboxamide prokineticin receptor antagonists
12/21/2010US7855199 antitumor agents such as 2-(2-difluoromethyl-4-methoxybenzimidazol-1 -yl)-4-(cis-2,6-dimethylmorpholino)-6-morpholinopyrimidine, used for inhibiting the growth of a human colon cancer cell, a human lung cancer cell, a human breast cancer cell or a human prostate cancer cell
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2532067C N-methyle-substituted benzamidazoles
12/21/2010CA2527132C Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
12/21/2010CA2503117C Substituted 4-alkoxyoxazol derivatives as ppar agonists
12/21/2010CA2457575C 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
12/16/2010WO2010144647A1 Nicotinamide compounds useful as kinase modulators
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143158A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010WO2010143116A1 Fluorinated aminotriazole derivatives
12/16/2010WO2010142985A1 Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142801A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010WO2010142735A1 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010WO2010142628A1 Pyrazole oxadiazole derivatives as s1p1 agonists
12/16/2010WO2010129467A8 Compounds and methods for inhibition of renin, and indications therefor
12/16/2010WO2010092591A3 Crystalline polymorphs of 5-[[(2r,3s)-2-[(1r)-1-[3,5- bis(trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2- dihydro-3h-1,2,4-triazol-3-one and process for preparation thereof
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010US20100317848 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
12/16/2010US20100317842 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
12/16/2010US20100317670 Therapeutic agents useful for treating pain
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317663 Anilinopyridines as inhibitors of fak
12/16/2010US20100317662 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286
12/16/2010US20100317660 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/16/2010US20100317659 Jak kinase modulating compounds and methods of use thereof
12/16/2010US20100317656 IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPEUTICS
12/16/2010US20100317653 Oxadiazole derivatives as dgat inhibitors
12/16/2010US20100317652 Compounds Useful In Therapy
12/16/2010US20100317648 Therapeutic compounds
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317643 Janus kinase inhibitor compounds and methods
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317607 Use of compounds for preparing anti-tuberculosis agents
12/16/2010US20100317568 Anti-Viral Compounds
12/16/2010US20100317543 Methine-substituted cyanine dye compounds
12/16/2010US20100317025 Diagnostic Method for Celiac Sprue
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/16/2010US20100316605 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2765181A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010CA2764823A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764694A1 Pyridinyl derivatives asinhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010CA2763683A1 Pyrazole oxadiazole derivatives as s1p1 agonists
12/16/2010CA2760887A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010CA2760588A1 Fluorinated aminotriazole derivatives
12/15/2010EP2261224A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/15/2010EP2261221A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261216A2 Pyrazoles as glucokinase activators
12/15/2010EP2260028A2 Selective androgen receptor modulators
12/15/2010EP2260022A1 Substituted cyclohexyldiamines
12/15/2010EP2260020A1 Hydroxamate-based inhibitors of deacetylases b
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010CN1909909B 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
12/15/2010CN101918399A Amino 1,2,4-triazole derivatives as modulators of MGLUR5
12/15/2010CN101918398A 4,4-disubstituted piperidines
12/15/2010CN101918397A Photoactive compound and photosensitive resin composition comprising the same
12/15/2010CN101918396A Organic compounds
12/15/2010CN101918395A Triazole oxadiazoles derivatives
12/15/2010CN101918389A Inhibitors of histone deacetylase
12/15/2010CN101918376A 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
12/15/2010CN101918372A Process for preparing N-substituted hydroxypyrimidinone carboxamides
12/15/2010CN101918371A Amide derivatives as sirtuin modulators
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 647